脂質ナノ粒子市場は、2024年の2億7,180万ドルから2029年には3億5,050万ドルに成長し、予測期間中のCAGRは5.2%になると予想されます。脂質ナノ粒子市場の主要企業には、Avanti Polar Lipids (Croda International plc (米国)、Merck KGaA (ドイツ)、Evonik Industries AG (ドイツ)、FUJIFILM Pharmaceuticals U.S.A., Inc. (米国)、日本ファインケミカル(日本)、Recipharm AB (スウェーデン)、Emergent (米国)、EUROAPI (フランス)、Cayman Chemica l(米国)、CordenPharma (スイス)、NOF CORPORATION (日本)、Precision NanoSystems (カナダ)、Gattefossé (フランス)、Acuitas Therapeutics (カナダ)、 Creative Biolabs (米国)、Curapath (スペイン)、Lipoid GmbH (ドイツ)、Nanocs, Inc. (米国)、MedKoo Biosciences, Inc. (米国)、Polysciences, Inc .(米国)、BIOVECTRA (カナダ)、Ascendia Pharmaceuticals (米国)、Curia Global, Inc. (米国)、IOI Oleo GmbH (ドイツ)、Vernal Biosciences (米国)。
目次
TABLE OF CONTENTS
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS (Page No. - 51)
4.1 LNP RAW MATERIALS & SERVICES MARKET OVERVIEW
4.2 ASIA PACIFIC: LNP RAW MATERIALS & SERVICES MARKET, BY PRODUCT
4.3 LNP RAW MATERIALS & SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 LNP RAW MATERIALS MARKET, BY END USER, 2023
4.5 LNP SERVICES MARKET, BY END USER, 2023
5 MARKET OVERVIEW (Page No. - 55)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing use of lipid nanoparticles in anti-cancer research
5.2.1.2 High uptake in RNA-based therapeutic research
5.2.1.3 Growing government focus on R&D for LNP-based drugs
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory requirements
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for advanced drug delivery systems
5.2.4 CHALLENGES
5.2.4.1 Challenges associated with LNP formulation
5.2.5 INDUSTRY TRENDS
5.2.5.1 Growing preference for personalized medicine and targeted drug delivery
5.2.5.2 Advancements in mRNA-based vaccine technology
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 PRICING ANALYSIS
5.4.1 INDICATIVE SELLING PRICE OF LNP PRODUCTS, BY KEY PLAYER
5.4.2 INDICATIVE SELLING PRICE, BY PRODUCT
5.5 SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.7.1 LNP RAW MATERIALS & SERVICES MARKET: ROLE IN ECOSYSTEM
5.8 TECHNOLOGY ANALYSIS
5.8.1 KEY TECHNOLOGIES
5.8.1.1 Nanotechnology-based drug delivery
5.8.1.2 Nucleic acid delivery
5.8.2 COMPLEMENTARY TECHNOLOGIES
5.8.2.1 Drug encapsulation techniques
5.8.2.2 Surface modification and functionalization technologies
5.8.3 ADJACENT TECHNOLOGIES
5.8.3.1 Biotechnology & genetic engineering technologies
5.8.3.2 Nanotechnology-based formulation techniques
5.9 PATENT ANALYSIS
5.9.1 PATENTS FILED, BY DOCUMENT TYPE, 2014-2023
5.9.2 INNOVATION AND PATENT APPLICATIONS
5.9.3 TOP APPLICANTS
5.10 KEY CONFERENCES & EVENTS, 2024-2025
5.11 REGULATORY LANDSCAPE
5.11.1 REGULATORY SCENARIO
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 PORTER’S FIVE FORCES ANALYSIS
5.12.1 DEGREE OF COMPETITION
5.12.2 BARGAINING POWER OF SUPPLIERS
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 THREAT OF SUBSTITUTES
5.12.5 THREAT OF NEW ENTRANTS
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR LIPID NANOPARTICLES: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.14 KEY BUYING CRITERIA
5.14.1 BUYING CRITERIA FOR LNP RAW MATERIALS
5.14.2 BUYING CRITERIA FOR LNP RAW MATERIALS, BY END USER
5.14.3 BUYING CRITERIA FOR LNP SERVICES
5.14.4 BUYING CRITERIA FOR LNP SERVICES, BY END USER
5.15 INVESTMENT & FUNDING SCENARIO
5.16 IMPACT OF GENERATIVE AI ON LNP RAW MATERIALS & SERVICES MARKET
6 LNP RAW MATERIALS MARKET, BY PRODUCT (Page No. - 90)
6.1 INTRODUCTION
6.2 IONIZABLE LIPIDS
6.2.1 HIGH DEMAND FOR MRNA-BASED VACCINES TO PROPEL MARKET
6.3 PEGYLATED LIPIDS
6.3.1 GROWING FOCUS ON NUCLEIC ACID MEDICINES TO BOOST DEMAND
6.4 NEUTRAL LIPIDS
6.4.1 ENHANCED STABILITY AND HIGH UPTAKE IN THERAPEUTIC APPLICATIONS TO DRIVE MARKET
6.5 PHOSPHOLIPIDS
6.5.1 BIOLOGICAL COMPATIBILITY AND CUSTOMIZATION FEATURES TO SUPPORT MARKET GROWTH
6.6 KITS & REAGENTS
6.6.1 ADVANCEMENTS IN LNP FORMULATION TECHNIQUES TO DRIVE MARKET
6.7 OTHER FORMULATION MATERIALS
7 LNP RAW MATERIALS MARKET, BY LNP TYPE (Page No. - 102)
7.1 INTRODUCTION
7.2 SOLID LIPID NANOPARTICLES (SLNS)
7.2.1 ADVANTAGES OVER CONVENTIONAL DRUG CARRIERS TO DRIVE MARKET
7.3 NANOSTRUCTURED LIPID CARRIERS (NLCS)
7.3.1 HIGH DRUG LOADING CAPACITY TO PROPEL MARKET
7.4 OTHER LNP TYPES
8 LNP RAW MATERIALS MARKET, BY MOLECULE TYPE (Page No. - 111)
8.1 INTRODUCTION
8.2 SIRNA
8.2.1 GROWING FOCUS ON TARGETED DRUG DELIVERY TO DRIVE MARKET
8.3 MRNA
8.3.1 GROWING UPTAKE IN VACCINE DEVELOPMENT TO PROPEL MARKET
8.4 OTHER MOLECULES
9 LNP RAW MATERIALS MARKET, BY APPLICATION (Page No. - 121)
9.1 INTRODUCTION
9.2 COMMERCIAL APPLICATIONS
9.2.1 POLYNEUROPATHY
9.2.1.1 Ability to provide targeted & sustained release of therapeutic agents to boost demand
9.2.2 COVID-19
9.2.2.1 Enhanced stability and distribution of mRNA to drive market
9.3 CLINICAL APPLICATIONS
9.3.1 COVID-19
9.3.1.1 Threat of evolving emerging variants to fuel uptake
9.3.2 CANCER
9.3.2.1 Increasing focus on oncology therapeutics to drive market
9.3.3 OTHER CLINICAL APPLICATIONS
10 LNP RAW MATERIALS MARKET, BY END USER (Page No. - 140)
10.1 INTRODUCTION
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.2.1 INCREASING DRUG DEVELOPMENT ACTIVITIES TO FUEL MARKET
10.3 ACADEMIC & RESEARCH INSTITUTES
10.3.1 HIGH FOCUS ON R&D FOR GENE THERAPY AND MEDICATION ADMINISTRATION TO DRIVE MARKET
10.4 CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS (CDMOS)
10.4.1 GROWING OUTSOURCING OF LNP FORMULATION SERVICES TO PROPEL MARKET
11 LNP SERVICES MARKET, BY SERVICE TYPE (Page No. - 149)
11.1 INTRODUCTION
11.2 FORMULATION DEVELOPMENT SERVICES
11.2.1 GROWING FOCUS ON TARGETED & EFFECTIVE DRUG DELIVERY TO PROPEL MARKET
11.3 MANUFACTURING SERVICES
11.3.1 RISING DEMAND FOR LIPID-BASED CARRIERS FOR GENE THERAPY AND VACCINE DEVELOPMENT TO DRIVE MARKET
11.4 OTHER SERVICES
12 LNP SERVICES MARKET, BY END USER (Page No. - 154)
12.1 INTRODUCTION
12.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
12.2.1 DRUG DEVELOPMENT & COMMERCIALIZATION TO PROPEL MARKET
12.3 ACADEMIC & RESEARCH INSTITUTES
12.3.1 ACCESS TO ADVANCED INFRASTRUCTURE AND SPECIALIZED EXPERTISE TO SUPPORT MARKET GROWTH
13 LNP RAW MATERIALS & SERVICES MARKET, BY REGION (Page No. - 158)
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
13.2.2 US
13.2.2.1 High pharmaceutical R&D expenditure to drive market
13.2.3 CANADA
13.2.3.1 Growing focus on personalized medicine to drive market
13.3 EUROPE
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
13.3.2 GERMANY
13.3.2.1 Rising development activities for LNP production to drive market
13.3.3 UK
13.3.3.1 Pioneering research programs for drug delivery systems to boost demand
13.3.4 FRANCE
13.3.4.1 Government funding for proteomics and genomics research to support market growth
13.3.5 ITALY
13.3.5.1 Growth in life sciences research to propel market
13.3.6 SPAIN
13.3.6.1 Growing demand for cancer therapeutics to drive market
13.3.7 REST OF EUROPE
13.4 ASIA PACIFIC
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
13.4.2 CHINA
13.4.2.1 Low manufacturing costs and rising outsourcing of services to CDMOs to drive market
13.4.3 JAPAN
13.4.3.1 Demand for LNP-based mRNA vaccines to fuel market
13.4.4 INDIA
13.4.4.1 Growth in pharmaceutical industry to drive market
13.4.5 SOUTH KOREA
13.4.5.1 Rising number of clinical trials to boost demand
13.4.6 AUSTRALIA
13.4.6.1 Growing requirement for innovative drug delivery systems to propel market
13.4.7 REST OF ASIA PACIFIC
13.5 LATIN AMERICA
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
13.5.2 BRAZIL
13.5.2.1 Global manufacturing hub for pharmaceutical drugs to fuel uptake
13.5.3 MEXICO
13.5.3.1 Large target patient population and demand for novel drug delivery technology to drive market
13.5.4 REST OF LATIN AMERICA
13.6 MIDDLE EAST
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
13.6.2 GCC COUNTRIES
13.6.2.1 Economic & healthcare expansion to support market growth
13.6.3 REST OF MIDDLE EAST
13.7 AFRICA
13.7.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
13.7.2 MACROECONOMIC OUTLOOK FOR AFRICA
14 COMPETITIVE LANDSCAPE (Page No. - 238)
14.1 INTRODUCTION
14.2 KEY PLAYER STRATEGY/RIGHT TO WIN
14.3 REVENUE ANALYSIS
14.4 MARKET SHARE ANALYSIS
14.4.1 LNP SERVICES MARKET
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
14.5.1 STARS
14.5.2 EMERGING LEADERS
14.5.3 PERVASIVE PLAYERS
14.5.4 PARTICIPANTS
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
14.5.5.1 Company footprint
14.5.5.2 Product footprint
14.5.5.3 Application footprint
14.5.5.4 Service type footprint
14.5.5.5 Region footprint
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
14.6.1 PROGRESSIVE COMPANIES
14.6.2 RESPONSIVE COMPANIES
14.6.3 DYNAMIC COMPANIES
14.6.4 STARTING BLOCKS
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
14.7 COMPANY VALUATION & FINANCIAL METRICS
14.7.1 FINANCIAL METRICS
14.7.2 COMPANY VALUATION
14.8 BRAND/PRODUCT COMPARISON ANALYSIS
14.9 COMPETITIVE SCENARIO
14.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
14.9.2 DEALS
14.9.3 EXPANSIONS
15 COMPANY PROFILES (Page No. - 261)
15.1 KEY PLAYERS
15.1.1 AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC)
15.1.1.1 Business overview
15.1.1.2 Products/Services offered
15.1.1.3 Recent developments
15.1.1.3.1 Deals
15.1.1.4 MnM view
15.1.1.4.1 Key strengths
15.1.1.4.2 Strategic choices
15.1.1.4.3 Weaknesses & competitive threats
15.1.2 MERCK KGAA
15.1.2.1 Business overview
15.1.2.2 Products/Services offered
15.1.2.3 Recent developments
15.1.2.3.1 Deals
15.1.2.3.2 Expansions
15.1.2.4 MnM view
15.1.2.4.1 Key strengths
15.1.2.4.2 Strategic choices
15.1.2.4.3 Weaknesses & competitive threats
15.1.3 EVONIK INDUSTRIES AG
15.1.3.1 Business overview
15.1.3.2 Products/Services offered
15.1.3.3 Recent developments
15.1.3.3.1 Deals
15.1.3.4 MnM view
15.1.3.4.1 Key strengths
15.1.3.4.2 Strategic choices
15.1.3.4.3 Weaknesses & competitive threats
15.1.4 NIPPON FINE CHEMICAL
15.1.4.1 Business overview
15.1.4.2 Products/Services offered
15.1.4.3 MnM view
15.1.4.3.1 Key strengths
15.1.4.3.2 Strategic choices
15.1.4.3.3 Weaknesses & competitive threats
15.1.5 NOF CORPORATION
15.1.5.1 Business overview
15.1.5.2 Products/Services offered
15.1.5.3 Recent developments
15.1.5.3.1 Deals
15.1.5.4 MnM view
15.1.5.4.1 Key strengths
15.1.5.4.2 Strategic choices
15.1.5.4.3 Weaknesses & competitive threats
15.1.6 FUJIFILM PHARMACEUTICALS U.S.A., INC. (FUJIFILM HOLDINGS CORPORATION)
15.1.6.1 Business overview
15.1.6.2 Products/Services offered
15.1.6.3 Recent developments
15.1.6.3.1 Expansions
15.1.7 PRECISION NANOSYSTEMS (CYTIVA)
15.1.7.1 Business overview
15.1.7.2 Products/Services offered
15.1.7.3 Recent developments
15.1.7.3.1 Product/Service launches
15.1.7.3.2 Deals
15.1.7.3.3 Expansions
15.1.8 RECIPHARM AB
15.1.8.1 Business overview
15.1.8.2 Products/Services offered
15.1.8.3 Recent developments
15.1.8.3.1 Deals
15.1.9 EMERGENT
15.1.9.1 Business overview
15.1.9.2 Products/Services offered
15.1.9.3 Recent developments
15.1.9.3.1 Deals
15.1.10 EUROAPI
15.1.10.1 Business overview
15.1.10.2 Products/Services offered
15.1.11 CAYMAN CHEMICAL
15.1.11.1 Business overview
15.1.11.2 Products/Services offered
15.1.12 CORDENPHARMA
15.1.12.1 Business overview
15.1.12.2 Products/Services offered
15.1.12.3 Recent developments
15.1.12.3.1 Product/Service launches
15.1.12.3.2 Deals
15.1.12.3.3 Expansions
15.1.13 GATTEFOSSÉ
15.1.13.1 Business overview
15.1.13.2 Products/Services offered
15.1.14 ACUITAS THERAPEUTICS
15.1.14.1 Business overview
15.1.14.2 Products/Services offered
15.1.14.3 Recent developments
15.1.14.3.1 Deals
15.1.15 IOI OLEO GMBH
15.1.15.1 Business overview
15.1.15.2 Products/Services offered
15.2 OTHER PLAYERS
15.2.1 CREATIVE BIOLABS
15.2.2 CURAPATH
15.2.3 LIPOID GMBH
15.2.4 NANOCS INC.
15.2.5 MEDKOO BIOSCIENCES, INC.
15.2.6 POLYSCIENCES INC.
15.2.7 BIOVECTRA
15.2.8 ASCENDIA PHARMACEUTICALS
15.2.9 CURIA GLOBAL, INC.
15.2.10 VERNAL BIOSCIENCES
16 APPENDIX (Page No. - 308)
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
LIST OF TABLES (398 TABLES)
TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 2 RISK ANALYSIS
TABLE 3 LNP RAW MATERIALS & SERVICES MARKET: IMPACT ANALYSIS
TABLE 4 INDICATIVE PRICING OF LNP PRODUCTS, BY KEY PLAYER
TABLE 5 INDICATIVE PRICING OF LNP PRODUCTS, BY TYPE
TABLE 6 PATENTS FILED, 2014-2023
TABLE 7 INDICATIVE LIST OF PATENTS IN LNP RAW MATERIALS & SERVICES MARKET
TABLE 8 LNP RAW MATERIALS & SERVICES MARKET: LIST OF CONFERENCES & EVENTS (2024−2025)
TABLE 9 REGULATORY SCENARIO
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 LNP RAW MATERIALS & SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 16 BUYING CRITERIA FOR LNP RAW MATERIALS, BY END USER
TABLE 17 LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 18 IONIZABLE LIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 19 NORTH AMERICA: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 20 EUROPE: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 22 LATIN AMERICA: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 23 MIDDLE EAST: IONIZABLE LIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 24 PEGYLATED LIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 25 NEUTRAL LIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 26 NORTH AMERICA: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 27 EUROPE: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 29 LATIN AMERICA: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 30 MIDDLE EAST: NEUTRAL LIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 31 PHOSPHOLIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 32 NORTH AMERICA: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 33 EUROPE: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 35 LATIN AMERICA: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 36 MIDDLE EAST: PHOSPHOLIPIDS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 37 KITS & REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 38 OTHER FORMULATION MATERIALS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 39 LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 40 SOLID LIPID NANOPARTICLES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 41 NORTH AMERICA: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 42 EUROPE: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 43 ASIA PACIFIC: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 44 LATIN AMERICA: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 45 MIDDLE EAST: SOLID LIPID NANOPARTICLES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 46 NANOSTRUCTURED LIPID CARRIERS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 47 NORTH AMERICA: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 48 EUROPE: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 49 ASIA PACIFIC: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 50 LATIN AMERICA: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 51 MIDDLE EAST: NANOSTRUCTURED LIPID CARRIERS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 52 OTHER LNP TYPES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 53 NORTH AMERICA: OTHER LNP TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 54 EUROPE: OTHER LNP TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 55 ASIA PACIFIC: OTHER LNP TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 56 LATIN AMERICA: OTHER LNP TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 57 MIDDLE EAST: OTHER LNP TYPES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 58 LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 59 LNP RAW MATERIALS MARKET FOR SIRNA, BY REGION, 2022-2029 (USD MILLION)
TABLE 60 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 61 EUROPE: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 62 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 63 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 64 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR SIRNA, BY REGION, 2022-2029 (USD MILLION)
TABLE 65 LNP RAW MATERIALS MARKET FOR MRNA, BY REGION, 2022-2029 (USD MILLION)
TABLE 66 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 67 EUROPE: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 68 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 69 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 70 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR MRNA, BY REGION, 2022-2029 (USD MILLION)
TABLE 71 LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY REGION, 2022-2029 (USD MILLION)
TABLE 72 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 73 EUROPE: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 74 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 75 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 76 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY REGION, 2022-2029 (USD MILLION)
TABLE 77 LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 78 LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 79 LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 80 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 81 EUROPE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 82 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 83 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 84 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 85 LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY REGION, 2022-2029 (USD MILLION)
TABLE 86 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 87 EUROPE: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 88 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 89 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 90 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY REGION, 2022-2029 (USD MILLION)
TABLE 91 LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY REGION, 2022-2029 (USD MILLION)
TABLE 92 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 93 EUROPE: LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 94 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 95 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 96 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COVID-19 (COMMERCIAL APPLICATIONS), BY REGION, 2022-2029 (USD MILLION)
TABLE 97 LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 98 LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 99 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 100 EUROPE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 101 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 102 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 103 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 104 LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY REGION, 2022-2029 (USD MILLION)
TABLE 105 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 106 EUROPE: LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 107 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 108 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 109 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY REGION, 2022-2029 (USD MILLION)
TABLE 110 LNP RAW MATERIALS MARKET FOR CANCER, BY REGION, 2022-2029 (USD MILLION)
TABLE 111 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 112 EUROPE: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 113 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 114 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 115 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CANCER, BY REGION, 2022-2029 (USD MILLION)
TABLE 116 LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 117 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 118 EUROPE: LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 119 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 120 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 121 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR OTHER DISEASES, BY REGION, 2022-2029 (USD MILLION)
TABLE 122 LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 123 LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 124 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 125 EUROPE: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 126 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 127 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 128 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 129 LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 130 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 131 EUROPE: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 132 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 133 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 134 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 135 LNP RAW MATERIALS MARKET FOR CDMOS, BY REGION, 2022-2029 (USD MILLION)
TABLE 136 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 137 EUROPE: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 138 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 139 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 140 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CDMOS, BY REGION, 2022-2029 (USD MILLION)
TABLE 141 LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
TABLE 142 FORMULATION DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 143 MANUFACTURING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 144 OTHER SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 145 LNP SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 146 LNP SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 147 LNP SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 148 LNP RAW MATERIALS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 149 LNP SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 150 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 151 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 152 NORTH AMERICA: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
TABLE 153 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 154 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 155 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 156 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 157 NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 158 NORTH AMERICA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 159 NORTH AMERICA: LNP SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 160 US: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 161 US: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 162 US: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 163 US: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 164 US: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 165 US: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 166 US: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 167 CANADA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 168 CANADA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 169 CANADA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 170 CANADA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 171 CANADA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 172 CANADA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 173 CANADA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 174 EUROPE: LNP RAW MATERIALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 175 EUROPE: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 176 EUROPE: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
TABLE 177 EUROPE: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 178 EUROPE: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 179 EUROPE: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 180 EUROPE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 181 EUROPE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 182 EUROPE: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 183 EUROPE: LNP SERVICES MARKET BY END USER, 2022-2029 (USD MILLION)
TABLE 184 GERMANY: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 185 GERMANY: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 186 GERMANY: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 187 GERMANY: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 188 GERMANY: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 189 GERMANY: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 190 GERMANY: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 191 UK: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 192 UK: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 193 UK: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 194 UK: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 195 UK: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 196 UK: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 197 UK: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 198 FRANCE: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 199 FRANCE: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 200 FRANCE: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 201 FRANCE: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 202 FRANCE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 203 FRANCE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 204 FRANCE: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 205 ITALY: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 206 ITALY: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 207 ITALY: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 208 ITALY: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 209 ITALY: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 210 ITALY: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 211 ITALY: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 212 SPAIN: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 213 SPAIN: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 214 SPAIN: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 215 SPAIN: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 216 SPAIN: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 217 SPAIN: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 218 SPAIN: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 219 REST OF EUROPE: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 220 REST OF EUROPE: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 221 REST OF EUROPE: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 222 REST OF EUROPE: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 223 REST OF EUROPE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 224 REST OF EUROPE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 225 REST OF EUROPE: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 226 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 227 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 228 ASIA PACIFIC: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
TABLE 229 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 230 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 231 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 232 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 233 ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 234 ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 235 ASIA PACIFIC: LNP SERVICES MARKET BY END USER, 2022-2029 (USD MILLION)
TABLE 236 CHINA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 237 CHINA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 238 CHINA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 239 CHINA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 240 CHINA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 241 CHINA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 242 CHINA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 243 JAPAN: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 244 JAPAN: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 245 JAPAN: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 246 JAPAN: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 247 JAPAN: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 248 JAPAN: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 249 JAPAN: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 250 INDIA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 251 INDIA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 252 INDIA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 253 INDIA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 254 INDIA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 255 INDIA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 256 INDIA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 257 SOUTH KOREA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 258 SOUTH KOREA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 259 SOUTH KOREA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 260 SOUTH KOREA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 261 SOUTH KOREA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 262 SOUTH KOREA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 263 SOUTH KOREA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 264 AUSTRALIA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 265 AUSTRALIA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 266 AUSTRALIA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 267 AUSTRALIA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 268 AUSTRALIA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE,2022-2029 (USD MILLION)
TABLE 269 AUSTRALIA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 270 AUSTRALIA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 271 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 272 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 273 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 274 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 275 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 276 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 277 REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 278 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 279 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 280 LATIN AMERICA: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
TABLE 281 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 282 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 283 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 284 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 285 LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 286 LATIN AMERICA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 287 LATIN AMERICA: LNP SERVICES MARKET BY END USER, 2022-2029 (USD MILLION)
TABLE 288 BRAZIL: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 289 BRAZIL: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 290 BRAZIL: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 291 BRAZIL: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 292 BRAZIL: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 293 BRAZIL: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 294 BRAZIL: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 295 MEXICO: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 296 MEXICO: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 297 MEXICO: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 298 MEXICO: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 299 MEXICO: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 300 MEXICO: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 301 MEXICO: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 302 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 303 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 304 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 305 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 306 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 307 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 308 REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 309 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 310 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 311 MIDDLE EAST: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
TABLE 312 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 313 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 314 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 315 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 316 MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 317 MIDDLE EAST: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 318 MIDDLE EAST: LNP SERVICES MARKET BY END USER, 2022-2029 (USD MILLION)
TABLE 319 GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 320 GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 321 GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 322 GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 323 GCC COUNTRIES: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE,2022-2029 (USD MILLION)
TABLE 324 GCC COUNTRIES: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 325 GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 326 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 327 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 328 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 329 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 330 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE,2022-2029 (USD MILLION)
TABLE 331 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 332 REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 333 AFRICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 334 AFRICA: LNP SERVICES MARKET, BY SERVICE TYPE, 2022-2029 (USD MILLION)
TABLE 335 AFRICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2022-2029 (USD MILLION)
TABLE 336 AFRICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2022-2029 (USD MILLION)
TABLE 337 AFRICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 338 AFRICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 339 AFRICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 340 AFRICA: LNP RAW MATERIALS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 341 AFRICA: LNP SERVICES MARKET BY END USER, 2022-2029 (USD MILLION)
TABLE 342 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 343 LNP RAW MATERIALS MARKET: DEGREE OF COMPETITION
TABLE 344 LNP SERVICES MARKET: TOP SERVICE PROVIDERS (2023)
TABLE 345 LNP RAW MATERIALS & SERVICES MARKET: PRODUCT FOOTPRINT
TABLE 346 LNP RAW MATERIALS & SERVICES MARKET: APPLICATION FOOTPRINT
TABLE 347 LNP RAW MATERIALS & SERVICES MARKET: SERVICE TYPE FOOTPRINT
TABLE 348 LNP RAW MATERIALS & SERVICES MARKET: REGION FOOTPRINT
TABLE 349 LNP RAW MATERIALS & SERVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 350 LNP RAW MATERIALS & SERVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 351 LNP RAW MATERIALS & SERVICES MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JUNE 2024
TABLE 352 LNP RAW MATERIALS & SERVICES MARKET: DEALS, JANUARY 2021−JUNE 2024
TABLE 353 LNP RAW MATERIALS & SERVICES MARKET: EXPANSIONS, JANUARY 2021−JUNE 2024
TABLE 354 AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): COMPANY OVERVIEW
TABLE 355 AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): PRODUCTS/SERVICES OFFERED
TABLE 356 AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): DEALS, JANUARY 2021-JUNE 2024
TABLE 357 MERCK KGAA: COMPANY OVERVIEW
TABLE 358 MERCK KGAA: PRODUCTS/SERVICES OFFERED
TABLE 359 MERCK KGAA: DEALS, JANUARY 2021-JUNE 2024
TABLE 360 MERCK KGAA: EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 361 EVONIK INDUSTRIES AG: COMPANY OVERVIEW
TABLE 362 EVONIK INDUSTRIES AG: PRODUCTS/SERVICES OFFERED
TABLE 363 EVONIK INDUSTRIES AG: DEALS, JANUARY 2021-JUNE 2024
TABLE 364 NIPPON FINE CHEMICAL CO., LTD.: COMPANY OVERVIEW
TABLE 365 NIPPON FINE CHEMICAL CO., LTD.: PRODUCTS/SERVICES OFFERED
TABLE 366 NOF CORPORATION: COMPANY OVERVIEW
TABLE 367 NOF CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 368 NOF CORPORATION: DEALS, JANUARY 2021-JUNE 2024
TABLE 369 FUJIFILM PHARMACEUTICALS U.S.A., INC.: COMPANY OVERVIEW
TABLE 370 FUJIFILM PHARMACEUTICALS U.S.A., INC.: PRODUCTS/SERVICES OFFERED
TABLE 371 FUJIFILM PHARMACEUTICALS U.S.A., INC.: EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 372 PRECISION NANOSYSTEMS: COMPANY OVERVIEW
TABLE 373 PRECISION NANOSYSTEMS: PRODUCTS/SERVICES OFFERED
TABLE 374 PRECISION NANOSYSTEMS: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JUNE 2024
TABLE 375 PRECISION NANOSYSTEMS: DEALS, JANUARY 2021-JUNE 2024
TABLE 376 PRECISION NANOSYSTEMS: EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 377 RECIPHARM AB: COMPANY OVERVIEW
TABLE 378 RECIPHARM AB: PRODUCTS/SERVICES OFFERED
TABLE 379 RECIPHARM AB: DEALS, JANUARY 2021-JUNE 2024
TABLE 380 EMERGENT: COMPANY OVERVIEW
TABLE 381 EMERGENT: PRODUCTS/SERVICES OFFERED
TABLE 382 EMERGENT: DEALS, JANUARY 2021-JUNE 2024
TABLE 383 EUROAPI: COMPANY OVERVIEW
TABLE 384 EUROAPI: PRODUCTS/SERVICES OFFERED
TABLE 385 CAYMAN CHEMICAL: COMPANY OVERVIEW
TABLE 386 CAYMAN CHEMICAL: PRODUCTS/SERVICES OFFERED
TABLE 387 CORDENPHARMA: COMPANY OVERVIEW
TABLE 388 CORDENPHARMA: PRODUCTS/SERVICES OFFERED
TABLE 389 CORDENPHARMA: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JUNE 2024
TABLE 390 CORDENPHARMA: DEALS, JANUARY 2021-JUNE 2024
TABLE 391 CORDENPHARMA: EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 392 GATTEFOSSÉ: COMPANY OVERVIEW
TABLE 393 GATTEFOSSÉ: PRODUCTS/SERVICES OFFERED
TABLE 394 ACUITAS THERAPEUTICS: COMPANY OVERVIEW
TABLE 395 ACUITAS THERAPEUTICS: PRODUCTS/SERVICES OFFERED
TABLE 396 ACUITAS THERAPEUTICS: DEALS, JANUARY 2021-JUNE 2024
TABLE 397 IOI OLEO GMBH: COMPANY OVERVIEW
TABLE 398 IOI OLEO GMBH: PRODUCTS/SERVICES OFFERED
LIST OF FIGURES (53 FIGURES)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 LNP RAW MATERIALS & SERVICES MARKET: BREAKDOWN OF PRIMARIES
FIGURE 3 LNP RAW MATERIALS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 4 LNP SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 5 MARKET SIZE ESTIMATION (RAW MATERIALS): APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
FIGURE 6 MARKET SIZE ESTIMATION (SERVICES): APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
FIGURE 7 ILLUSTRATIVE EXAMPLE OF NOF CORPORATION: REVENUE SHARE ANALYSIS (2023)
FIGURE 8 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 10 LNP RAW MATERIALS MARKET (SUPPLY SIDE): CAGR PROJECTIONS
FIGURE 11 LNP SERVICES MARKET (SUPPLY SIDE): CAGR PROJECTIONS
FIGURE 12 DATA TRIANGULATION METHODOLOGY
FIGURE 13 LNP RAW MATERIALS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 14 LNP RAW MATERIALS MARKET, BY LNP TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 15 LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 16 LNP RAW MATERIALS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 17 LNP RAW MATERIALS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 18 LNP SERVICES MARKET, BY SERVICE TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 19 LNP SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 20 LNP RAW MATERIALS & SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 INCREASING USE OF LIPID NANOPARTICLES IN RNA-BASED THERAPIES TO PROPEL LNP RAW MATERIALS MARKET
FIGURE 22 IONIZABLE LIPIDS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
FIGURE 23 JAPAN IS EXPECTED TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 24 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 25 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 26 LNP RAW MATERIALS & SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 27 REVENUE SHIFT AND NEW REVENUE POCKETS FOR LNP RAW MATERIAL MANUFACTURERS
FIGURE 28 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES
FIGURE 29 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
FIGURE 30 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING FORMULATION DEVELOPMENT & MANUFACTURING PHASE
FIGURE 31 LNP RAW MATERIALS & SERVICES MARKET: ECOSYSTEM ANALYSIS
FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR LIPID NANOPARTICLE PATENTS (JANUARY 2014-DECEMBER 2023)
FIGURE 33 LNP RAW MATERIALS & SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 34 NORTH AMERICA: LNP RAW MATERIALS MARKET SNAPSHOT
FIGURE 35 ASIA PACIFIC: LNP RAW MATERIALS MARKET SNAPSHOT
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN LNP RAW MATERIALS MARKET, 2019-2023 (USD MILLION)
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN LNP RAW MATERIALS MARKET (2023)
FIGURE 38 LNP RAW MATERIALS & SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 39 LNP RAW MATERIALS & SERVICES MARKET: COMPANY FOOTPRINT
FIGURE 40 LNP RAW MATERIALS & SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 41 EV/EBITDA OF KEY VENDORS
FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 43 LNP RAW MATERIALS & SERVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 44 AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): COMPANY SNAPSHOT (2023)
FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2023)
FIGURE 46 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2023)
FIGURE 47 NIPPON FINE CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2023)
FIGURE 48 NOF CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 49 FUJIFILM PHARMACEUTICALS U.S.A., INC.: COMPANY SNAPSHOT (2023)
FIGURE 50 RECIPHARM AB: COMPANY SNAPSHOT (2023)
FIGURE 51 EMERGENT: COMPANY SNAPSHOT (2023)
FIGURE 52 EUROAPI: COMPANY SNAPSHOT (2023)
FIGURE 53 IOI OLEO GMBH: COMPANY SNAPSHOT (2023)
